Delivery Order SPE2DB24D2100-SPE2DB25FBDUW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 150 ml quantity, valued at $1,807.02. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is scheduled for completion by June 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 180 ml quantity, with a contract ceiling value of $2,401.91. This is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, executed without a set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 180 ml quantity, with a ceiling value of $1,809.72. This is a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,051.38 on October 17, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 150 ml quantities, with an ultimate completion date of October 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The product will be delivered to AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 60 ml quantities, valued at $1,182.78. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract is issued as a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 ml suspension in a 120ml quantity, valued at $1,378.38. The contract, executed on August 19, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 20, 2025. This award carries no set-aside designation, indicating that it was competitively awarded among eligible vendors. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension (180 ml) with a ceiling value of $4,169.79. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an Indefinite Delivery Contract (IDC) mechanism. The order is due for completion by April 24, 2025, and will be performed at AmerisourceBergen's headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 60 ml quantity, with a contract value of $1,672.09 and completion deadline of September 26, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension in a 120 mL unit, with a contract ceiling value of $7,096.68. This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,640.47 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (180 mL). This is a firm fixed price delivery order with no set-aside designation, meaning it was awarded through open competition. The contract will be completed by September 17, 2025, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBDUWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml quantities, valued at $3,153.38. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by April 25, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally, encompassing a wide range of medications, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen Drug Corp maintains a significant role as a prime vendor for federal medical procurement, particularly supporting the Defense Health Agency and other government healthcare systems through this flexible contract arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 4/24/25 |